Trial Profile
A Phase II Double-Blind, Randomized, Placebo-controlled, Dose Escalation Study to Evaluate the Safety of AERAS-402 in Adults Recently Treated for Pulmonary Tuberculosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Tuberculosis vaccine (Primary)
- Indications Tuberculosis
- Focus Adverse reactions
- Sponsors Aeras; Crucell
- 06 Jan 2017 Results assessing safety and immunogenicity published in the American Journal of Respiratory and Critical Care Medicine.
- 18 May 2009 Actual initiation date added from Crucell media release.
- 18 Dec 2008 New trial record.